Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunologic Basis of Anti-IgE Therapy (Study II: On Patients With Asthma)

NCT00367016 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.

NCT NCT00367016
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00367016 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunologic Basis of Anti-IgE Therapy (Study II: On Patients With Asthma)
Lead sponsor
University of California, Davis
Phase
Phase 4
Overall status
Completed
Start date
February 29, 2004
Completion date
October 17, 2012
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergic rhinitis, asthma, atopic dermatitis